Lotte New York Palace Hotel

NRx Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Retrieved on: 
Thursday, September 7, 2023
Lotte New York Palace Hotel, Webcast, Madison, Medication, Conference, Nightclub

RADNOR, Pa., Sept. 7, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that Stephen Willard, J.D., Chief Executive Officer and Dr. Jonathan Javitt, Chief Scientist of NRx Pharmaceuticals, will present a company overview at the H.C. Wainwright 25th Annual Global Investment Conference.

Key Points: 
  • RADNOR, Pa., Sept. 7, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that Stephen Willard, J.D., Chief Executive Officer and Dr. Jonathan Javitt, Chief Scientist of NRx Pharmaceuticals, will present a company overview at the H.C. Wainwright 25th Annual Global Investment Conference.
  • The presentation is scheduled for Tuesday, September 12, 2023, at 5:00PM ET.
  • The in-person venue for the event is the Lotte New York Palace Hotel in New York City located at 455 Madison Avenue.
  • Virtual participation will be staged simultaneously with over 550 company presentations scheduled as live feed or available on-demand.

Adiso Therapeutics to Participate in Upcoming September Investor Conferences

Retrieved on: 
Thursday, September 7, 2023
Lotte New York Palace Hotel, Therapy, Patient, Inflammation, Pharmaceutical industry, Hotel

CONCORD, Mass., Sept. 7, 2023 /PRNewswire/ -- Adiso Therapeutics, Inc., a clinical-stage biotechnology company committed to creating medicines that treat inflammatory diseases and improve the lives of patients and their families, today announced that Scott Megaffin, Chief Executive Officer, and members of the Adiso Corporate Staff will participate in the following upcoming investor conferences:

Key Points: 
  • CONCORD, Mass., Sept. 7, 2023 /PRNewswire/ -- Adiso Therapeutics, Inc., a clinical-stage biotechnology company committed to creating medicines that treat inflammatory diseases and improve the lives of patients and their families, today announced that Scott Megaffin, Chief Executive Officer, and members of the Adiso Corporate Staff will participate in the following upcoming investor conferences:
    Location: Lotte New York Palace Hotel, New York City, NY
    Members of the Adiso management team will be available for one-on-one meetings during these conferences.

IRADIMED CORPORATION to Participate at Upcoming Investor Conferences

Retrieved on: 
Wednesday, September 6, 2023
Lake Street, The Yale Club of New York City, Yale Club, Growth, Lotte New York Palace Hotel, Conference, Life insurance, Hotel

WINTER SPRINGS, Fla., Sept. 06, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that the Company will be participating in two upcoming investor conferences.

Key Points: 
  • WINTER SPRINGS, Fla., Sept. 06, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that the Company will be participating in two upcoming investor conferences.
  • Iradimed management is scheduled to participate in investor meetings at the H.C. Wainwright 25th Annual Global Investment Conference on Tuesday and Wednesday, September 12-13, 2023, at the Lotte New York Palace Hotel in New York City.
  • Iradimed management will also be participating in investor meetings at the Lake St. Capital 7th Annual Best Ideas Growth Conference “Big7” on Thursday, September 14 at the Yale Club in New York City.

Citius Pharmaceuticals to Participate in H.C. Wainwright and Sidoti Investor Conferences in September 2023

Retrieved on: 
Wednesday, September 6, 2023
Sidoti, Citius, Altius, Fortius, Lotte New York Palace Hotel, Conference, Cryptocurrency

CRANFORD, N.J., Sept. 6, 2023 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced its participation in two investor conferences in September 2023.

Key Points: 
  • CRANFORD, N.J., Sept. 6, 2023 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced its participation in two investor conferences in September 2023.
  • Citius Chairman and CEO Leonard Mazur will present at the H.C. Wainwright 25th Annual Global Investment Conference on Monday, September 11, 2023, and at the Sidoti Small-Cap Virtual Conference on Wednesday, September 20, 2023.
  • 2:00 pm ET on September 11, 2023
    Lotte New York Palace Hotel, New York City

LM Funding America to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Retrieved on: 
Wednesday, September 6, 2023
Lotte New York Palace Hotel, HCW, Conference, LM, Cryptocurrency

TAMPA, FL, Sept. 06, 2023 (GLOBE NEWSWIRE) -- LM Funding America, Inc. (NASDAQ: LMFA) (“LM Funding” or the “Company”), a cryptocurrency mining and technology-based specialty finance company, today announced that Bruce M. Rodgers, Chairman and CEO of LM Funding America will be participating in the H.C. Wainwright (HCW) 25th Annual Global Investment Conference being held September 11-13, 2023 at the Lotte New York Palace Hotel in New York City.

Key Points: 
  • TAMPA, FL, Sept. 06, 2023 (GLOBE NEWSWIRE) -- LM Funding America, Inc. (NASDAQ: LMFA) (“LM Funding” or the “Company”), a cryptocurrency mining and technology-based specialty finance company, today announced that Bruce M. Rodgers, Chairman and CEO of LM Funding America will be participating in the H.C. Wainwright (HCW) 25th Annual Global Investment Conference being held September 11-13, 2023 at the Lotte New York Palace Hotel in New York City.
  • LM Funding’s presentation will be available on-demand to registered attendees via the conference platform beginning Monday, September 11, 2023, at 7:00 AM Eastern Time.
  • A webcast of the Company’s presentation can also be accessed at https://journey.ct.events/view/0d40387d-30aa-4aeb-a670-f33b6cefa1c4 and on the investor relations section of Company’s website at https://www.lmfunding.com/investors .
  • Management will be participating in one-on-one meetings with qualified members of the investor community throughout the conference in New York City.

HCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 – 13, 2023

Retrieved on: 
Wednesday, September 6, 2023
Anantara New York Palace Budapest Hotel, Pancreatic cancer, Patent, Masonic Cancer Center, University, University of Minnesota, United States Patent and Trademark Office, Clinical trial, Cancer, Ageing, Gynecologic Oncology (journal), Research, Inflammation, Cell, MRC Laboratory of Molecular Biology, EDT, Trial of the century, Drug resistance, Molecular biology, National Cancer Institute, Professor, Patient, Division, Colorectal cancer, Department of Obstetrics and Gynecology (Massachusetts General Hospital), Immune system, Gynaecology, UMN, Principal, Lotte New York Palace Hotel, NCI, Notifiable disease, Immunosuppression, Natural killer T cell, Laboratory, Conference, Pharmaceutical industry, Vaccine, Obstetrics

On September 12, 2023, the Company will be meeting individual investors in person at the conference venue, the Lotte New York Palace Hotel in New York.

Key Points: 
  • On September 12, 2023, the Company will be meeting individual investors in person at the conference venue, the Lotte New York Palace Hotel in New York.
  • In addition, a pre-recorded, virtual Company update will be available on demand beginning at 7:00 a.m. EDT on September 11, 2023 for all who register for the conference.
  • Due to clinical protocol requirements, dosing of the remaining patients is expected to take place in the next 3 to 6 months.
  • Dr. Geller stated, “Our team is very excited to bring this clinical trial to patients who have recurrent cancer.

Processa Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Retrieved on: 
Wednesday, September 6, 2023
PCSA, Lotte New York Palace Hotel, Cancer, Patient, Conference, Safety, Pharmaceutical industry, Cryptocurrency, MD

HANOVER, MD, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from cancer, announces that Chief Executive Officer George Ng will present a corporate overview at the at the H.C. Wainwright 25th Annual Global Investment Conference.

Key Points: 
  • HANOVER, MD, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from cancer, announces that Chief Executive Officer George Ng will present a corporate overview at the at the H.C. Wainwright 25th Annual Global Investment Conference.
  • The conference is being held on September 11 – 13, 2023 at the Lotte New York Palace Hotel.
  • Mr. Ng and Chief Financial Officer James Stanker will be available for one-on-one meetings throughout the conference.
  • Investors can attend the conference and request a meeting with management by registering for the conference using the link below:

Ocular Therapeutix™ to Present at Three Upcoming Investor Conferences

Retrieved on: 
Wednesday, September 6, 2023
Eye, Lotte New York Palace Hotel, Hotel

BEDFORD, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will participate at the following conferences:

Key Points: 
  • BEDFORD, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will participate at the following conferences:
    Location: Lotte New York Palace Hotel, New York, NY
    Management will be available throughout the day for investor meetings at all three conferences.
  • If you plan to attend at least one of the conferences and are interested in meeting with management, please contact your H.C. Wainwright, Baird or Cantor representative.

Data Storage Corporation to Present at the H.C. Wainwright 25th Annual Global Investment Conference on September 12th

Retrieved on: 
Wednesday, September 6, 2023
Lotte New York Palace Hotel, Data storage, Conference, Cryptocurrency

MELVILLE, N.Y., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Data Storage Corporation (Nasdaq: DTST) (“DSC” and the “Company”), a provider of diverse business continuity solutions for disaster-recovery, cloud infrastructure, cyber-security, and IT services, today announced that it will be participating in the H.C. Wainwright 25th Annual Global Investment Conference being held September 11-13, 2023 at the Lotte New York Palace Hotel in New York City.

Key Points: 
  • MELVILLE, N.Y., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Data Storage Corporation (Nasdaq: DTST) (“DSC” and the “Company”), a provider of diverse business continuity solutions for disaster-recovery, cloud infrastructure, cyber-security, and IT services, today announced that it will be participating in the H.C. Wainwright 25th Annual Global Investment Conference being held September 11-13, 2023 at the Lotte New York Palace Hotel in New York City.
  • Chuck Piluso, CEO of Data Storage, is scheduled to present on Tuesday, September 12, 2023 at 4:30 p.m. Eastern Time.
  • The presentation will be webcast live and can be accessed at https://journey.ct.events/view/678dc22d-4038-47c5-80b0-b6b3fb3aba1e and on the investor relations section of the company’s website at https://www.dtst.com .
  • Management will also be participating in one-on-one meetings with qualified members of the investor community throughout the conference in New York City.

GoLogiq Plans to Present at the 25th Annual H.C. Wainwright, September 11-13, 2023

Retrieved on: 
Wednesday, September 6, 2023
Fintech, CMA, Sale, OTC, Lotte New York Palace Hotel, Conference, Cryptocurrency

The conference will feature on-demand presentations by companies across a range of industries.

Key Points: 
  • The conference will feature on-demand presentations by companies across a range of industries.
  • GoLogiq CEO Granger Whitelaw will be joined by the company’s chairman Brent Suen for virtual one-on-one meetings with investors and analysts held throughout the day.
  • Management will discuss the company’s market leadership in providing financial services through technology-based solutions in both emerging and developed markets.
  • For questions or further information about GoLogiq, please contact Ron Both of CMA at +1 (949) 432-7557 or submit your request here .